| Tango Therapeutics, Inc. | 10.9M | US$340M | 25.6% |
| Revolution Medicines, Inc. | 500K | US$93.6M | 7.1% |
| Abivax Sa | 605K | US$80.6M | 6.1% |
| Kodiak Sciences Inc | 1.48M | US$57.6M | 4.3% |
| Kymera Therapeutics, Inc. | 429K | US$49.2M | 3.7% |
| Definium Therapeutics, Inc. | 999K | US$47M | 3.5% |
| Replimune Group, Inc. | 3.98M | US$44.1M | 3.3% |
| Celcuity Inc. | 417K | US$43.6M | 3.3% |
| Q32 Bio Inc. | 3.15M | US$40.1M | 3.0% |
| Capricor Therapeutics, Inc. | 1.4M | US$33.6M | 2.5% |
| Precigen, Inc. | 5.15M | US$29.4M | 2.2% |
| Corcept Therapeutics Incorporated | 336K | US$29.2M | 2.2% |
| Surrozen, Inc. | 1.11M | US$27M | 2.0% |
| Protagonist Therapeutics, Inc. | 170K | US$20.8M | 1.6% |
| Vir Biotechnology, Inc. | 1.87M | US$19M | 1.4% |
| Vaxcyte, Inc. | 325K | US$18.9M | 1.4% |
| Corvus Pharmaceuticals, Inc. | 1.1M | US$16.4M | 1.2% |
| Ptc Therapeutics, Inc. | 200K | US$16.3M | 1.2% |
| Praxis Precision Medicines, Inc. | 46,457 | US$15.6M | 1.2% |
| Amylyx Pharmaceuticals, Inc. | 800K | US$14.4M | 1.1% |
| Ocular Therapeutix, Inc. | 1.3M | US$12.8M | 0.96% |
| Opus Genetics, Inc. | 2.81M | US$11.6M | 0.87% |
| Palisade Bio, Inc. | 4.8M | US$10M | 0.76% |
| Apogee Therapeutics, Inc. | 70,000 | US$9.29M | 0.70% |
| Spyre Therapeutics, Inc. | 100K | US$8.88M | 0.67% |
| Cogent Biosciences, Inc. | 225K | US$8.71M | 0.66% |
| Cytokinetics, Incorporated | 100K | US$8.52M | 0.64% |
| Relay Therapeutics, Inc. | 450K | US$8.42M | 0.63% |
| Contineum Therapeutics, Inc. | 494K | US$8.1M | 0.61% |
| Shattuck Labs, Inc. | 1M | US$6.94M | 0.52% |
| Avalo Therapeutics, Inc. | 375K | US$6.93M | 0.52% |
| Forte Biosciences, Inc. | 275K | US$5.83M | 0.44% |
| Relmada Therapeutics, Inc. | 842K | US$5.83M | 0.44% |
| Zura Bio Limited | 900K | US$5.31M | 0.40% |
| Cybin, Inc. | 790K | US$5.22M | 0.39% |
| Odyssey Therapeutics, Inc. | 275K | US$5.15M | 0.39% |
| Sensei Biotherapeutics, Inc. | 181K | US$4.51M | 0.34% |
| Oric Pharmaceuticals, Inc. | 350K | US$3.79M | 0.29% |
| An2 Therapeutics, Inc. | 749K | US$3.63M | 0.27% |
| Neumora Therapeutics, Inc. | 2M | US$3.4M | 0.26% |
| Inovio Pharmaceuticals, Inc. | 2.84M | US$3.13M | 0.24% |
| Allogene Therapeutics, Inc. | 1.5M | US$3.12M | 0.23% |
| Solid Biosciences Inc. | 300K | US$3M | 0.23% |
| Karyopharm Therapeutics Inc. | 303K | US$2.96M | 0.22% |
| Clene Inc. | 478K | US$2.94M | 0.22% |
| Sarepta Therapeutics, Inc. | 150K | US$2.7M | 0.20% |
| Maplight Therapeutics, Inc. | 75,000 | US$2.69M | 0.20% |
| Nurix Therapeutics, Inc. | 100K | US$2.43M | 0.18% |
| Lb Pharmaceuticals Inc | 70,000 | US$2.27M | 0.17% |
| Edesa Biotech, Inc. | 205K | US$1.67M | 0.13% |
| Invivyd, Inc. | 1.5M | US$1.31M | 0.10% |
| Upstream Bio, Inc. | 150K | US$1.04M | 0.08% |
| Milestone Pharmaceuticals Inc. | 667K | US$893K | 0.07% |
| Pepgen Inc. | 273K | US$491K | 0.04% |
| Regenxbio Inc. | 15,000 | US$180K | 0.01% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |